Detalhe da pesquisa
1.
The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumor.
Pediatr Blood Cancer
; : e30358, 2023 Jun 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37347686
2.
Initial genome sequencing and analysis of multiple myeloma.
Nature
; 471(7339): 467-72, 2011 Mar 24.
Artigo
Inglês
| MEDLINE | ID: mdl-21430775
3.
A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myeloma.
Cancer
; 122(21): 3327-3335, 2016 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27433944
4.
Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach.
Blood
; 121(16): 3147-52, 2013 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-23422747
5.
Bendamustine, lenalidomide, and dexamethasone (BRD) is highly effective with durable responses in relapsed multiple myeloma.
Am J Hematol
; 90(12): 1106-10, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26331432
6.
US physician perspective on the use of biomarker and ctDNA testing in patients with melanoma.
Crit Rev Oncol Hematol
; 196: 104289, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38341119
7.
Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma.
Haematologica
; 98(10): 1586-92, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23716545
8.
Activity of pemetrexed in pre-clinical chordoma models and humans.
Sci Rep
; 13(1): 7317, 2023 05 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37147496
9.
Mapping the landscape of genetic dependencies in chordoma.
Nat Commun
; 14(1): 1933, 2023 04 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37024492
10.
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias.
Nat Cancer
; 4(5): 754-773, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37237081
11.
Selinexor inhibits growth of patient derived chordomas in vivo as a single agent and in combination with abemaciclib through diverse mechanisms.
Front Oncol
; 12: 808021, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36059685
12.
Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity.
Cell Rep Med
; 2(1): 100188, 2021 01 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33521702
13.
Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins.
Cell Rep
; 34(1): 108532, 2021 01 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33406420
14.
A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5.
Blood Cancer J
; 8(3): 35, 2018 03 21.
Artigo
Inglês
| MEDLINE | ID: mdl-29563506
15.
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models.
Cancer Chemother Pharmacol
; 59(5): 561-74, 2007 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-17160391
16.
Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 17(9): 555-562, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28735890
17.
Discovery and SAR of Novel 2,3-Dihydroimidazo[1,2-c]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80-6946).
ChemMedChem
; 11(14): 1517-30, 2016 07 19.
Artigo
Inglês
| MEDLINE | ID: mdl-27310202
18.
Molecular complexes that contain both c-Cbl and c-Src associate with Golgi membranes.
Eur J Cell Biol
; 81(1): 26-35, 2002 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-11893076
19.
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.
Cancer Cell
; 25(1): 91-101, 2014 Jan 13.
Artigo
Inglês
| MEDLINE | ID: mdl-24434212
20.
SAR of a novel 'Anthranilamide Like' series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer.
Bioorg Med Chem Lett
; 17(15): 4378-81, 2007 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17574417